• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Introduction to 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic Acid (CAS No. 1261947-85-6)

2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid (CAS No. 1261947-85-6) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its intricate aromatic structure, exhibits a unique combination of functional groups that make it a promising candidate for various biochemical applications. The presence of both methoxy and ethoxy substituents on the benzene ring, coupled with a carboxylic acid moiety, imparts distinct chemical properties that are leveraged in synthetic chemistry and drug discovery processes.

The molecular structure of 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid consists of a phenyl ring substituted at the 4-position with an ethoxy group and at the 2-position with a methyl group, while the 5-position features a methoxy group. This arrangement creates a molecule with potential interactions across multiple biological pathways, making it an attractive scaffold for developing novel therapeutic agents. The compound’s solubility profile and stability under various conditions further enhance its utility in laboratory settings and preclinical studies.

In recent years, there has been growing interest in exploring the pharmacological potential of 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid due to its structural analogies with known bioactive molecules. Research studies have begun to uncover its potential role in modulating inflammatory responses and antioxidant activities. For instance, preliminary in vitro investigations suggest that this compound may interact with enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are pivotal in the biosynthesis of pro-inflammatory mediators. By inhibiting these enzymes, 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid could potentially serve as a lead compound for developing anti-inflammatory drugs with reduced side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

Moreover, the methoxy and ethoxy groups in the molecule contribute to its ability to act as a hydrogen donor or acceptor, facilitating various redox reactions crucial for cellular homeostasis. This property has led researchers to investigate its antioxidant capabilities, particularly in mitigating oxidative stress induced by reactive oxygen species (ROS). Oxidative stress is implicated in numerous pathological conditions, including neurodegenerative diseases, cardiovascular disorders, and certain types of cancer. Thus, compounds like 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid hold promise as candidates for therapeutic intervention.

Recent advancements in computational chemistry have also played a pivotal role in understanding the binding interactions of 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid with biological targets. Molecular docking simulations have revealed that this compound can bind effectively to several protein receptors involved in metabolic pathways and signal transduction cascades. For example, studies indicate that it may interact with peroxisome proliferator-activated receptors (PPARs), which are transcription factors critical for regulating lipid metabolism and glucose homeostasis. Such interactions could make 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid a valuable tool in developing treatments for metabolic syndromes.

The synthesis of 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include Friedel-Crafts alkylation followed by hydroxylation and esterification steps. The use of advanced catalytic systems has improved the efficiency of these synthetic pathways, making large-scale production more feasible. Additionally, green chemistry principles have been increasingly applied to minimize waste and energy consumption during synthesis, aligning with sustainable pharmaceutical practices.

In conclusion, 2-(4-ethoxy-2-methylphenyl)-5-methoxybenzoic acid (CAS No. 1261947-85-6) represents a fascinating compound with diverse pharmacological implications. Its unique structural features enable interactions with multiple biological targets, suggesting potential applications in anti-inflammatory, antioxidant, and metabolic disorder treatments. As research continues to unfold the therapeutic possibilities of this molecule, it is poised to become an important intermediate in drug discovery programs aimed at addressing critical human health challenges.

• 38087-96-6(2-(3-Methoxyphenyl)benzoic acid)
• 15144-81-7([1,1'-Biphenyl]-2-carboxylicacid, 5-methoxy-)
• 893736-32-8(2-(3-Benzyloxyphenyl)benzoic acid)
• 833485-16-8(Benzoic acid, 3-([1,1'-biphenyl]-2-ylmethoxy)-)
• 1261997-66-3(2-(3-ethoxyphenyl)-5-methylbenzoic Acid)
• 1261938-46-8(2-methyl-6-(3-phenylmethoxyphenyl)benzoic Acid)
• 1261938-56-0(5-methyl-2-(3-phenylmethoxyphenyl)benzoic Acid)
• 1261981-31-0(5-methoxy-2-(3-phenylmethoxyphenyl)benzoic Acid)
• 1261928-81-7(2-(4-ethoxy-2-methylphenyl)-5-methylbenzoic Acid)
• 669713-70-6(2-BIPHENYL-(3'-ETHOXY)CARBOXYLIC ACID)